Last reviewed · How we verify

Nalfurafine Hydrochloride Orally Disintegrating Tablets

Shandong New Time Pharmaceutical Co., LTD · Phase 1 active Small molecule

Nalfurafine Hydrochloride Orally Disintegrating Tablets is a Small molecule drug developed by Shandong New Time Pharmaceutical Co., LTD. It is currently in Phase 1 development.

At a glance

Generic nameNalfurafine Hydrochloride Orally Disintegrating Tablets
SponsorShandong New Time Pharmaceutical Co., LTD
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nalfurafine Hydrochloride Orally Disintegrating Tablets

What is Nalfurafine Hydrochloride Orally Disintegrating Tablets?

Nalfurafine Hydrochloride Orally Disintegrating Tablets is a Small molecule drug developed by Shandong New Time Pharmaceutical Co., LTD.

Who makes Nalfurafine Hydrochloride Orally Disintegrating Tablets?

Nalfurafine Hydrochloride Orally Disintegrating Tablets is developed by Shandong New Time Pharmaceutical Co., LTD (see full Shandong New Time Pharmaceutical Co., LTD pipeline at /company/shandong-new-time-pharmaceutical-co-ltd).

What development phase is Nalfurafine Hydrochloride Orally Disintegrating Tablets in?

Nalfurafine Hydrochloride Orally Disintegrating Tablets is in Phase 1.

Related